205 related articles for article (PubMed ID: 36805625)
1. CanVasc consensus recommendations for the use of avacopan in antineutrophil cytoplasm antibody-associated vasculitis: 2022 addendum.
Turgeon D; Bakowsky V; Baldwin C; Cabral DA; Clements-Baker M; Clifford A; Cohen Tervaert JW; Dehghan N; Ennis D; Famorca L; Fifi-Mah A; Girard LP; Lefebvre F; Liang P; Makhzoum JP; Massicotte-Azarniouch D; Mendel A; Milman N; Reich HN; Robinson DB; Ross C; Rumsey DG; Soowamber M; Towheed TE; Trudeau J; Twilt M; Yacyshyn E; Yardimci GK; Khalidi N; Barra L; Pagnoux C
Rheumatology (Oxford); 2023 Aug; 62(8):2646-2651. PubMed ID: 36805625
[TBL] [Abstract][Full Text] [Related]
2. CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitis: 2020 Update.
Mendel A; Ennis D; Go E; Bakowsky V; Baldwin C; Benseler SM; Cabral DA; Carette S; Clements-Baker M; Clifford AH; Cohen Tervaert JW; Cox G; Dehghan N; Dipchand C; Dhindsa N; Famorca L; Fifi-Mah A; Garner S; Girard LP; Lessard C; Liang P; Noone D; Makhzoum JP; Milman N; Pineau CA; Reich HN; Rhéaume M; Robinson DB; Rumsey DG; Towheed TE; Trudeau J; Twilt M; Yacyshyn E; Yeung RSM; Barra LB; Khalidi N; Pagnoux C
J Rheumatol; 2021 Apr; 48(4):555-566. PubMed ID: 32934123
[TBL] [Abstract][Full Text] [Related]
3. Management of antineutrophil cytoplasmic antibody-associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendations.
Casal Moura M; Gauckler P; Anders HJ; Bruchfeld A; Fernandez-Juarez GM; Floege J; Frangou E; Goumenos D; Segelmark M; Turkmen K; van Kooten C; Tesar V; Geetha D; Fervenza FC; Jayne DRW; Stevens KI; Kronbichler A
Nephrol Dial Transplant; 2023 Oct; 38(11):2637-2651. PubMed ID: 37164940
[TBL] [Abstract][Full Text] [Related]
4. CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitides.
McGeoch L; Twilt M; Famorca L; Bakowsky V; Barra L; Benseler SM; Cabral DA; Carette S; Cox GP; Dhindsa N; Dipchand CS; Fifi-Mah A; Goulet M; Khalidi N; Khraishi MM; Liang P; Milman N; Pineau CA; Reich HN; Samadi N; Shojania K; Taylor-Gjevre R; Towheed TE; Trudeau J; Walsh M; Yacyshyn E; Pagnoux C;
J Rheumatol; 2016 Jan; 43(1):97-120. PubMed ID: 26523024
[TBL] [Abstract][Full Text] [Related]
5. Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): part 1-treatment of granulomatosis with polyangiitis and microscopic polyangiitis.
Schirmer JH; Sanchez-Alamo B; Hellmich B; Jayne D; Monti S; Luqmani RA; Tomasson G
RMD Open; 2023 Jul; 9(3):. PubMed ID: 37479496
[TBL] [Abstract][Full Text] [Related]
6. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update.
Hellmich B; Sanchez-Alamo B; Schirmer JH; Berti A; Blockmans D; Cid MC; Holle JU; Hollinger N; Karadag O; Kronbichler A; Little MA; Luqmani RA; Mahr A; Merkel PA; Mohammad AJ; Monti S; Mukhtyar CB; Musial J; Price-Kuehne F; Segelmark M; Teng YKO; Terrier B; Tomasson G; Vaglio A; Vassilopoulos D; Verhoeven P; Jayne D
Ann Rheum Dis; 2024 Jan; 83(1):30-47. PubMed ID: 36927642
[TBL] [Abstract][Full Text] [Related]
7. [Cortisone-free rheumatology-Vasculitides].
Holle JU; Moosig F
Z Rheumatol; 2021 May; 80(4):314-321. PubMed ID: 33709164
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of avacopan in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: A subanalysis of a randomized Phase 3 study.
Harigai M; Kaname S; Tamura N; Dobashi H; Kubono S; Yoshida T
Mod Rheumatol; 2023 Mar; 33(2):338-345. PubMed ID: 35482532
[TBL] [Abstract][Full Text] [Related]
9. Avacopan as an additional therapeutic intervention to promote renal recovery in severe ANCA-associated vasculitis: A case report.
Atrens AD; Hutton H; O'Sullivan E; Moore J; Madhan K
Nephrology (Carlton); 2024 Feb; 29(2):105-107. PubMed ID: 37985226
[TBL] [Abstract][Full Text] [Related]
10. Updates in ANCA-associated vasculitis.
Ross C; Makhzoum JP; Pagnoux C
Eur J Rheumatol; 2022 Jul; 9(3):153-166. PubMed ID: 35156630
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis.
Beketova TV
Ter Arkh; 2018 May; 90(5):13-22. PubMed ID: 30701885
[TBL] [Abstract][Full Text] [Related]
12. Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of microscopic polyangiitis and granulomatosis with polyangiitis: The 2023 update - secondary publication.
Sada KE; Nagasaka K; Kaname S; Nango E; Kishibe K; Dobashi H; Hiromura K; Kawakami T; Bando M; Wada T; Amano K; Murakawa Y; Harigai M
Mod Rheumatol; 2024 Mar; 34(3):559-567. PubMed ID: 37599461
[TBL] [Abstract][Full Text] [Related]
13. Renal improvement and remission in a patient with refractory ANCA-associated vasculitis treated with avacopan.
Alvarez L; Kambham N; Su R
J Nephrol; 2023 Nov; 36(8):2365-2370. PubMed ID: 37036661
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the 2022 ACR/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Previous Criteria.
Pyo JY; Lee LE; Park YB; Lee SW
Yonsei Med J; 2023 Jan; 64(1):11-17. PubMed ID: 36579374
[TBL] [Abstract][Full Text] [Related]
15. How the Availability of Anti-C5a Agents Could Change the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Roccatello D; Fenoglio R; Oddone V; Sciascia S
Kidney Blood Press Res; 2022; 47(8):506-513. PubMed ID: 35665698
[TBL] [Abstract][Full Text] [Related]
16. Thrombocytopenia during avacopan administration: A case report.
Morimoto N; Mori T; Shioji S; Watanabe H; Sakai K; Mori K; Yamamura A; Hanioka A; Akagi Y; Fujiki T; Mandai S; Mori Y; Ando F; Susa K; Iimori S; Naito S; Sohara E; Uchida S
Int J Rheum Dis; 2023 Aug; 26(8):1603-1607. PubMed ID: 36880594
[TBL] [Abstract][Full Text] [Related]
17. Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis.
Berti A; Cornec D; Dua AB
Rheum Dis Clin North Am; 2023 Aug; 49(3):545-561. PubMed ID: 37331732
[TBL] [Abstract][Full Text] [Related]
18. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
Lally L; Spiera R
Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
[TBL] [Abstract][Full Text] [Related]
19. Diagnosing and treating ANCA-associated vasculitis: an updated review for clinical practice.
Chevet B; Cornec D; Casal Moura M; Cornec-Le Gall E; Fervenza FC; Warrington KJ; Specks U; Berti A
Rheumatology (Oxford); 2023 May; 62(5):1787-1803. PubMed ID: 36315063
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacological and clinical profiles of avacopan (TAVNEOS
Maruyama Y; Yoshida T; Maruyama I
Nihon Yakurigaku Zasshi; 2023 Sep; 158(5):399-407. PubMed ID: 37460300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
